Importance of early life factors found in new lung cancer research

Published Date: 08 Mar 2023

A groundbreaking study by the University of Bristol and the University of Essex has revealed new insights into the importance of early childhood for lung health.

Read Full News

Todays Updates


NeurologyLive® Friday 5 — January 9, 2026 Isabella Ciccone, MPH


Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 9, 2026.

Oral Anticoagulants Do Not Raise ARIA Risk of Anti-Amyloid Alzheimer Therapies, Study Shows Louie Pasculli


A review of clinical trial and real-world data found no evidence that oral anticoagulants increase brain imaging abnormalities in patients treated with lecanemab or donanemab for early Alzheimer disease.

Inside the 2026 MDA Conference: Emerging Research Themes in Neuromuscular Medicine Marco Meglio, Angela Lek, PhD


Angela Lek, PhD, chief research officer at the Muscular Dystrophy Association, provided an outlook on the 2026 MDA meeting and what clinicians should look forward to in preparation.

NeurologyLive® Brain Games: January 11, 2025 Marco Meglio, Louie Pasculli


Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on epilepsy comorbidities!

Phase 3 Trial Supports Subcutaneous Anifrolumab in Systemic Lupus Erythematosus


Phase 3 Trial Supports Subcutaneous Anifrolumab in Systemic Lupus Erythematosus

5 Pulmonology Headlines You Missed in December 2025


5 Pulmonology Headlines You Missed in December 2025

Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery


Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Even after a partial ban, asbestos is still used and is a deadly carcinogen, according to the EPA.

2.

CAR-T cell therapy for cancer causes 'brain fog,' study shows

3.

Mutation Correlates with a Higher Prostate Cancer Mortality Risk.

4.

Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.

5.

ALK-positive lung cancer trial results show unprecedented progression-free survival.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot